Skip to main content

Table 2 HPV type distribution among HIV-infected and HIV-uninfected women at enrollment

From: A cross-sectional analysis of factors associated with detection of oncogenic human papillomavirus in human immunodeficiency virus-infected and uninfected Kenyan women

HPV TYPES HIV-INFECTED (N = 115) n (%) or mean (SD, range) HIV-UNINFECTED (N = 105) n (%) or mean (SD, range) UNADJUSTED MODEL ADJUSTED MODELi
OR or IRRl (95% CI) P-value aOR or aIRRm (95% CI) P-value
Any HPV typea 68 (59.1) 37 (35.2) 2.659 (1.540–4.592) <.001 3.117 (1.460–6.654) 0.003
HR-HPVb 54 (47.0) 29 (27.6) 2.319 (1.321–4.073) 0.003 3.301 (1.483–7.344) 0.003
IARC HR-HPVc 45 (39.1) 25 (23.8) 2.057 (1.146–3.691) 0.016 2.593 (1.147–5.860) 0.022
A9 HPVd 27 (23.5) 16 (15.2) 1.706 (0.860–3.385) 0.126 2.569 (1.023–6.447) 0.045
HPV 16 12 (10.4) 3 (2.9) 3.961 (1.086–14.454) 0.037 9.510 (1.757–51.463) 0.009
Non-HPV 16 A9e 20 (17.4) 13 (12.4) 1.490 (0.700–3.169) 0.301 1.590 (0.583–4.333) 0.365
A7 HPVf 23 (20.0) 9 (8.6) 2.667 (1.172–6.066) 0.019 3.813 (1.284–11.319) 0.016
HPV 18 4 (3.5) 1 (1.0) 3.748 (0.412–34.080) 0.241 4.583 (0.311–67.632) 0.268
HPV 68j 8 (7.0) 0 (0) 10.684 (2.684 - infk) 0.010 10.057 (1.803 - infk) 0.022
Non-HPV 18 A7g 20 (17.4) 8 (7.6) 2.553 (1.072–6.077) 0.034 3.320 (1.037–10.629) 0.043
Any LR-HPVh 37 (32.2) 18 (17.1) 2.293 (1.208–4.352) 0.011 2.122 (0.913–4.932) 0.080
≥2 Types Any HPV 38 (33.0) 11 (10.5) 4.217 (2.021–8.799) <.001 6.111 (2.265–16.483) <.001
≥2 Types HR-HPV 23 (20.0) 7 (6.7) 3.500 (1.433–8.544) 0.006 3.705 (1.195–11.488) 0.023
Number of HPV types 1.3 (1.7, 0–7) 0.6 (1.1, 0–8) 2.320 (1.557–3.457) <.001 2.585 (1.611–4.148) <.001
Number of HR-HPV types 0.9 (1.2, 0–6) 0.4 (0.7, 0–4) 2.294 (1.463–3.597) <.001 2.519 (1.476–4.299) 0.001
  1. aHPV 6, 11, 16, 18, 26, 31, 33, 35, 39, 40, 42, 45, 51, 52, 53, 54, 55, 56, 58, 59, 61, 62, 66, 67, 68, 69, 70, 71, 72, 73, 81, 82, 83, 84, CP6108, IS39
  2. bHigh-Risk HPV 16, 18, 26, 31, 33, 35, 39, 45, 51, 52, 53, 56, 58, 59, 66, 67, 68, 69, 70, 73, 82, IS39
  3. cHPV 16, 18, 31, 33, 35, 39, 45, 51 52, 56, 58, 59, 66
  4. dHPV 16, 31, 33, 35, 52, 58
  5. eHPV 31, 33, 35, 52, 58
  6. fHPV 18, 39, 45, 59, 68
  7. gHPV 39, 45, 59, 68
  8. hLow-Risk HPV 6, 11, 40, 42, 54, 55, 61, 62, 64, 71, 72, 81, 83, 84, CP6108
  9. iAge, marital status, educational level, home ownership, distance to health care, having medical conditions in the past 12 months, life-time sexual partners, age of first sex, condom use, accumulative years of birth control use, total number of pregnancy, and history of cervical cancer screening, smoking history, history of CT or GC were adjusted as covariates in the logistic regression model or the negative binomial regression model
  10. jExact logistic regression model was conducted for HPV 68 due to low cell sizes
  11. kInfinity
  12. lOdds ratio or Incidence rate ratio; mAdjusted odds ratio or adjusted incidence rate ratio